Provided by Tiger Trade Technology Pte. Ltd.

Acumen Pharmaceuticals, Inc.

2.61
-0.2800-9.69%
Post-market: 2.650.0400+1.53%19:49 EDT
Volume:369.34K
Turnover:1.01M
Market Cap:188.48M
PE:-1.59
High:2.95
Open:2.92
Low:2.59
Close:2.89
52wk High:3.60
52wk Low:1.21
Shares:72.21M
Float Shares:37.05M
Volume Ratio:0.97
T/O Rate:1.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6370
EPS(LYR):-2.0035
ROE:-120.50%
ROA:-45.77%
PB:3.29
PE(LYR):-1.30

Loading ...

Acumen Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Acumen Pharmaceuticals posts corporate presentation on sabirnetug Alzheimer’s drug candidate

Reuters
·
May 12

Acumen Pharmaceuticals Q1 net loss narrows

Reuters
·
May 12

Acumen Pharmaceuticals Q1 EPS $(0.33) Beats $(0.36) Estimate

Benzinga Earnings
·
May 12

BRIEF-Acumen Pharmaceuticals, Inc. Q1 Income From Operations USD -21.149 Million

Reuters
·
May 12

Acumen Pharmaceuticals, Inc. Q1 Net Income USD -20.737 Million

THOMSON REUTERS
·
May 12

Acumen Pharmaceuticals Inc - Expects to License Two Compounds From Jcr Pharmaceuticals in Q2 2026

THOMSON REUTERS
·
May 12

Acumen Pharmaceuticals, Inc. Q1 Basic EPS USD -0.33

THOMSON REUTERS
·
May 12

Press Release: Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights

Dow Jones
·
May 12

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 11

Acumen Pharmaceuticals Inc expected to post a loss of 40 cents a share - Earnings Preview

Reuters
·
May 08

Acumen Pharmaceuticals to join Bank of America Securities Health Care Conference fireside chat

Reuters
·
May 08

Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026

GlobeNewswire
·
May 06

Acumen Pharmaceuticals announces annual shareholder meeting via webcast

Reuters
·
Apr 24

BTIG Keeps Their Buy Rating on Acumen Pharmaceuticals (ABOS)

TIPRANKS
·
Apr 06

Acumen Pharmaceuticals’ Earnings Call: Promise Amid Pressure

TIPRANKS
·
Apr 05

Acumen files to sell 10.83M shares of common stock for holders

TIPRANKS
·
Mar 27

Acumen Pharmaceuticals Inc - Files for Offering of up to 10,833,331 Common Shares by the Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Mar 27

Acumen Pharmaceuticals Price Target Maintained With a $8.00/Share by BTIG

Dow Jones
·
Mar 27

Acumen Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 26